Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-18

FDA Approved: ARIPIPRAZOLE — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for aripiprazole from Torrent Pharmaceuticals Limited, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)